Invex Therapeutics Ltd (ASX:IXC)
0.110
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 8.27 million as of March 9, 2026. Its market cap has increased by 37.50% in one year.
Market Cap
8.27M
Enterprise Value
3.67M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 8.27M, a decrease of -86.02%. That is a compound annual growth rate of -25.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chimeric Therapeutics | 8.84M |
| Immuron | 9.80M |
| Tissue Repair | 9.98M |
| Biotron | 8.11M |
| Bio-Gene Technology | 11.29M |
| AdAlta | 11.47M |
| Vectus Biosystems | 6.68M |
| Zelira Therapeutics | 5.95M |